ID   B4GT1_HUMAN             Reviewed;         398 AA.
AC   P15291; B2R710; D3DRL2; Q12909; Q12910; Q12911; Q14456; Q14509;
AC   Q14523;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 5.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Beta-1,4-galactosyltransferase 1;
DE            Short=Beta-1,4-GalTase 1;
DE            Short=Beta4Gal-T1;
DE            Short=b4Gal-T1;
DE            EC=2.4.1.-;
DE   AltName: Full=UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1;
DE   AltName: Full=UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1;
DE   Includes:
DE     RecName: Full=Lactose synthase A protein;
DE              EC=2.4.1.22;
DE   Includes:
DE     RecName: Full=N-acetyllactosamine synthase;
DE              EC=2.4.1.90;
DE     AltName: Full=Nal synthase;
DE   Includes:
DE     RecName: Full=Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase;
DE              EC=2.4.1.38;
DE   Includes:
DE     RecName: Full=Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase;
DE              EC=2.4.1.-;
DE   Contains:
DE     RecName: Full=Processed beta-1,4-galactosyltransferase 1;
GN   Name=B4GALT1; Synonyms=GGTB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3144273; DOI=10.1016/S0006-291X(88)80300-0;
RA   Masri K.A., Appert H.E., Fukuda M.N.;
RT   "Identification of the full-length coding sequence for human
RT   galactosyltransferase (beta-N-acetylglucosaminide: beta 1,4-
RT   galactosyltransferase).";
RL   Biochem. Biophys. Res. Commun. 157:657-663(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2124683; DOI=10.1093/nar/18.23.7174;
RA   Watzele G., Berger E.G.;
RT   "Near identity of HeLa cell galactosyltransferase with the human
RT   placental enzyme.";
RL   Nucleic Acids Res. 18:7174-7174(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1903938; DOI=10.1016/0006-291X(91)90423-5;
RA   Mengle-Gaw L., McCoy-Haman M.F., Tiemeier D.C.;
RT   "Genomic structure and expression of human beta-1,4-
RT   galactosyltransferase.";
RL   Biochem. Biophys. Res. Commun. 176:1269-1276(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=1384956;
RA   Uejima T., Uemura M., Nozawa S., Narimatsu H.;
RT   "Complementary DNA cloning for galactosyltransferase associated with
RT   tumor and determination of antigenic epitopes recognized by specific
RT   monoclonal antibodies.";
RL   Cancer Res. 52:6158-6163(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7579794; DOI=10.1093/glycob/5.4.397;
RA   Kudo T., Narimatsu H.;
RT   "The beta 1, 4-galactosyltransferase gene is post-transcriptionally
RT   regulated during differentiation of mouse F9 teratocarcinoma cells.";
RL   Glycobiology 5:397-403(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal liver;
RX   PubMed=7540104; DOI=10.1016/1357-2725(94)00062-G;
RA   Chatterjee S.K., Mukerjee S., Tripathi P.K.;
RT   "Analysis of the sequences of human beta-1,4-galactosyltransferase
RT   cDNA clones.";
RL   Int. J. Biochem. Cell Biol. 27:329-336(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 138-398, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3094506; DOI=10.1016/S0006-291X(86)80094-8;
RA   Appert H.E., Rutherford T.J., Tarr G.E., Wiest J.S., Thomford N.R.,
RA   McCorquodale D.J.;
RT   "Isolation of a cDNA coding for human galactosyltransferase.";
RL   Biochem. Biophys. Res. Commun. 139:163-168(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 78-94.
RX   PubMed=3091013; DOI=10.1016/0006-291X(86)90269-X;
RA   Appert H.E., Rutherford T.J., Tarr G.E., Thomford N.R.,
RA   McCorquodale D.J.;
RT   "Isolation of galactosyltransferase from human milk and the
RT   determination of its N-terminal amino acid sequence.";
RL   Biochem. Biophys. Res. Commun. 138:224-229(1986).
RN   [12]
RP   PROTEIN SEQUENCE OF 274-326, CATALYTIC ACTIVITY, FUNCTION, AND
RP   MUTAGENESIS OF TYR-282; TYR-285; TYR-307; TRP-308 AND TRP-310.
RX   PubMed=2120039;
RA   Aoki D., Appert H.E., Johnson D., Wong S.S., Fukuda M.N.;
RT   "Analysis of the substrate binding sites of human
RT   galactosyltransferase by protein engineering.";
RL   EMBO J. 9:3171-3178(1990).
RN   [13]
RP   ALTERNATIVE INITIATION, AND SUBCELLULAR LOCATION.
RX   PubMed=1714903;
RA   Lopez L.C., Youakim A., Evans S.C., Shur B.D.;
RT   "Evidence for a molecular distinction between Golgi and cell surface
RT   forms of beta 1,4-galactosyltransferase.";
RL   J. Biol. Chem. 266:15984-15991(1991).
RN   [14]
RP   SUBUNIT.
RX   PubMed=7744867; DOI=10.1074/jbc.270.20.12170;
RA   Yamaguchi N., Fukuda M.N.;
RT   "Golgi retention mechanism of beta-1,4-galactosyltransferase.
RT   Membrane-spanning domain-dependent homodimerization and association
RT   with alpha- and beta-tubulins.";
RL   J. Biol. Chem. 270:12170-12176(1995).
RN   [15]
RP   REVIEW.
RX   PubMed=10580128; DOI=10.1016/S0304-4165(99)00168-3;
RA   Amado M., Almeida R., Schwientek T., Clausen H.;
RT   "Identification and characterization of large galactosyltransferase
RT   gene families: galactosyltransferases for all functions.";
RL   Biochim. Biophys. Acta 1473:35-53(1999).
RN   [16]
RP   INVOLVEMENT IN CDG2D.
RX   PubMed=11901181; DOI=10.1172/JCI0214010;
RA   Hansske B., Thiel C., Luebke T., Hasilik M., Hoening S., Peters V.,
RA   Heidemann P.H., Hoffmann G.F., Berger E.G., von Figura K., Koerner C.;
RT   "Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-
RT   galactosyltransferase I causes the congenital disorder of
RT   glycosylation type IId.";
RL   J. Clin. Invest. 109:725-733(2002).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 126-397 OF MUTANT HIS-340 IN
RP   COMPLEX WITH MANGANESE IONS AND N-ACETYL-D-GLUCOSAMINE, CATALYTIC
RP   ACTIVITY, FUNCTION, COFACTOR, MUTAGENESIS OF MET-340, AND DISULFIDE
RP   BONDS.
RX   PubMed=16157350; DOI=10.1016/j.jmb.2005.07.050;
RA   Ramasamy V., Ramakrishnan B., Boeggeman E., Ratner D.M.,
RA   Seeberger P.H., Qasba P.K.;
RT   "Oligosaccharide preferences of beta1,4-galactosyltransferase-I:
RT   crystal structures of Met340His mutant of human beta1,4-
RT   galactosyltransferase-I with a pentasaccharide and trisaccharides of
RT   the N-glycan moiety.";
RL   J. Mol. Biol. 353:53-67(2005).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 126-397 OF MUTANT HIS-340 IN
RP   COMPLEX WITH MANGANESE IONS AND UDP, COFACTOR, AND DISULFIDE BONDS.
RX   PubMed=16497331; DOI=10.1016/j.jmb.2006.01.088;
RA   Ramakrishnan B., Ramasamy V., Qasba P.K.;
RT   "Structural snapshots of beta-1,4-galactosyltransferase-I along the
RT   kinetic pathway.";
RL   J. Mol. Biol. 357:1619-1633(2006).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 126-398 IN COMPLEX WITH
RP   MANGANESE IONS AND N-ACETYL-D-GLUCOSAMINE, AND COFACTOR.
RX   PubMed=19106107; DOI=10.1074/jbc.M805782200;
RA   Brown J.R., Yang F., Sinha A., Ramakrishnan B., Tor Y., Qasba P.K.,
RA   Esko J.D.;
RT   "Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-
RT   galactosyltransferase 1 and selectin-mediated tumor metastasis.";
RL   J. Biol. Chem. 284:4952-4959(2009).
CC   -!- FUNCTION: The Golgi complex form catalyzes the production of
CC       lactose in the lactating mammary gland and could also be
CC       responsible for the synthesis of complex-type N-linked
CC       oligosaccharides in many glycoproteins as well as the carbohydrate
CC       moieties of glycolipids.
CC   -!- FUNCTION: The cell surface form functions as a recognition
CC       molecule during a variety of cell to cell and cell to matrix
CC       interactions, as those occurring during development and egg
CC       fertilization, by binding to specific oligosaccharide ligands on
CC       opposing cells or in the extracellular matrix.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + D-glucose = UDP +
CC       lactose.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-
CC       glucosaminylglycopeptide = UDP + beta-D-galactosyl-(1->4)-N-
CC       acetyl-beta-D-glucosaminylglycopeptide.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-D-glucosamine
CC       = UDP + N-acetyllactosamine.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:16157350,
CC         ECO:0000269|PubMed:16497331, ECO:0000269|PubMed:19106107};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Homodimer; and heterodimer with alpha-lactalbumin to form
CC       lactose synthase. Interacts (via N-terminal cytoplasmic domain)
CC       with UBE2Q1 (via N-terminus); the interaction is direct (By
CC       similarity). {ECO:0000250|UniProtKB:P15535,
CC       ECO:0000269|PubMed:16157350, ECO:0000269|PubMed:16497331,
CC       ECO:0000269|PubMed:19106107, ECO:0000269|PubMed:7744867}.
CC   -!- SUBCELLULAR LOCATION: Isoform Long: Golgi apparatus, Golgi stack
CC       membrane {ECO:0000269|PubMed:1714903}; Single-pass type II
CC       membrane protein. Cell membrane {ECO:0000269|PubMed:1714903};
CC       Single-pass type II membrane protein. Cell surface
CC       {ECO:0000269|PubMed:1714903}. Cell projection, filopodium
CC       {ECO:0000250|UniProtKB:P15535}. Note=Found in trans cisternae of
CC       Golgi but is mainly localized at the plasma membrane
CC       (PubMed:1714903). B4GALT1 cell surface expression is regulated by
CC       UBE2Q1 (By similarity). {ECO:0000250|UniProtKB:P15535,
CC       ECO:0000269|PubMed:1714903}.
CC   -!- SUBCELLULAR LOCATION: Isoform Short: Golgi apparatus, Golgi stack
CC       membrane {ECO:0000269|PubMed:1714903}; Single-pass type II
CC       membrane protein. Note=Found in trans cisternae of Golgi.
CC       {ECO:0000269|PubMed:1714903}.
CC   -!- SUBCELLULAR LOCATION: Processed beta-1,4-galactosyltransferase 1:
CC       Secreted {ECO:0000303|PubMed:2120039}. Note=Soluble form found in
CC       body fluids. {ECO:0000303|PubMed:2120039}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long; Synonyms=Cell surface;
CC         IsoId=P15291-1; Sequence=Displayed;
CC       Name=Short; Synonyms=Golgi complex;
CC         IsoId=P15291-2; Sequence=VSP_018802;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, but at very low levels
CC       in fetal and adult brain.
CC   -!- PTM: The soluble form derives from the membrane forms by
CC       proteolytic processing.
CC   -!- DISEASE: Congenital disorder of glycosylation 2D (CDG2D)
CC       [MIM:607091]: A multisystem disorder caused by a defect in
CC       glycoprotein biosynthesis and characterized by under-glycosylated
CC       serum glycoproteins. Congenital disorders of glycosylation result
CC       in a wide variety of clinical features, such as defects in the
CC       nervous system development, psychomotor retardation, dysmorphic
CC       features, hypotonia, coagulation disorders, and immunodeficiency.
CC       The broad spectrum of features reflects the critical role of N-
CC       glycoproteins during embryonic development, differentiation, and
CC       maintenance of cell functions. {ECO:0000269|PubMed:11901181}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 7 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Beta-1,4-galactosyltransferase 1;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_436";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14085; CAA32247.1; -; mRNA.
DR   EMBL; M22921; AAA35936.1; -; mRNA.
DR   EMBL; M22921; AAA35937.1; -; mRNA.
DR   EMBL; X55415; CAA39073.1; -; mRNA.
DR   EMBL; X55415; CAA39074.1; -; mRNA.
DR   EMBL; M70432; AAB00776.1; -; Genomic_DNA.
DR   EMBL; M70427; AAB00776.1; JOINED; Genomic_DNA.
DR   EMBL; M70428; AAB00776.1; JOINED; Genomic_DNA.
DR   EMBL; M70429; AAB00776.1; JOINED; Genomic_DNA.
DR   EMBL; M70430; AAB00776.1; JOINED; Genomic_DNA.
DR   EMBL; M70431; AAB00776.1; JOINED; Genomic_DNA.
DR   EMBL; X13223; CAA31611.1; -; mRNA.
DR   EMBL; D29805; BAA06188.1; -; mRNA.
DR   EMBL; U10472; AAA68218.1; -; mRNA.
DR   EMBL; U10473; AAA68219.1; -; mRNA.
DR   EMBL; U10474; AAA68220.1; -; mRNA.
DR   EMBL; CH471071; EAW58520.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58521.1; -; Genomic_DNA.
DR   EMBL; AK312797; BAG35657.1; -; mRNA.
DR   EMBL; AL161445; CAD13306.1; -; Genomic_DNA.
DR   EMBL; M13701; AAA35935.1; -; mRNA.
DR   CCDS; CCDS6535.1; -. [P15291-1]
DR   PIR; JQ1030; JQ1030.
DR   RefSeq; NP_001488.2; NM_001497.3. [P15291-1]
DR   UniGene; Hs.272011; -.
DR   PDB; 2AE7; X-ray; 2.00 A; A/B/C=126-398.
DR   PDB; 2AEC; X-ray; 2.00 A; A/B/C=126-398.
DR   PDB; 2AES; X-ray; 2.00 A; A/B/C=126-398.
DR   PDB; 2AGD; X-ray; 1.90 A; A/B/C=126-398.
DR   PDB; 2AH9; X-ray; 2.00 A; A/B/C=126-398.
DR   PDB; 2FY7; X-ray; 1.70 A; A=126-398.
DR   PDB; 2FYA; X-ray; 1.90 A; A=126-398.
DR   PDB; 2FYB; X-ray; 1.90 A; A=126-398.
DR   PDB; 3EE5; X-ray; 2.20 A; A/B/C=126-398.
DR   PDB; 4EE3; X-ray; 2.30 A; A/B/C=126-398.
DR   PDB; 4EE4; X-ray; 1.95 A; A/B/C=126-398.
DR   PDB; 4EE5; X-ray; 2.20 A; A/B/C=126-398.
DR   PDB; 4EEA; X-ray; 2.00 A; A/B/C=126-398.
DR   PDB; 4EEG; X-ray; 2.20 A; A/B/C=126-398.
DR   PDB; 4EEM; X-ray; 2.20 A; A/B/C=126-398.
DR   PDB; 4EEO; X-ray; 2.30 A; A/B/C=126-398.
DR   PDB; 4L41; X-ray; 2.70 A; C=126-398.
DR   PDBsum; 2AE7; -.
DR   PDBsum; 2AEC; -.
DR   PDBsum; 2AES; -.
DR   PDBsum; 2AGD; -.
DR   PDBsum; 2AH9; -.
DR   PDBsum; 2FY7; -.
DR   PDBsum; 2FYA; -.
DR   PDBsum; 2FYB; -.
DR   PDBsum; 3EE5; -.
DR   PDBsum; 4EE3; -.
DR   PDBsum; 4EE4; -.
DR   PDBsum; 4EE5; -.
DR   PDBsum; 4EEA; -.
DR   PDBsum; 4EEG; -.
DR   PDBsum; 4EEM; -.
DR   PDBsum; 4EEO; -.
DR   PDBsum; 4L41; -.
DR   ProteinModelPortal; P15291; -.
DR   SMR; P15291; -.
DR   BioGrid; 108950; 27.
DR   IntAct; P15291; 4.
DR   MINT; MINT-5004065; -.
DR   STRING; 9606.ENSP00000369055; -.
DR   BindingDB; P15291; -.
DR   ChEMBL; CHEMBL4384; -.
DR   DrugBank; DB03814; 2-(N-Morpholino)-Ethanesulfonic Acid.
DR   DrugBank; DB03013; Di(N-Acetyl-D-Glucosamine).
DR   DrugBank; DB03501; Galactose-uridine-5'-diphosphate.
DR   DrugBank; DB00141; N-Acetyl-D-glucosamine.
DR   DrugBank; DB03685; Uridine-5'-Monophosphate.
DR   CAZy; GT7; Glycosyltransferase Family 7.
DR   iPTMnet; P15291; -.
DR   PhosphoSitePlus; P15291; -.
DR   SwissPalm; P15291; -.
DR   BioMuta; B4GALT1; -.
DR   DMDM; 116241264; -.
DR   EPD; P15291; -.
DR   MaxQB; P15291; -.
DR   PaxDb; P15291; -.
DR   PeptideAtlas; P15291; -.
DR   PRIDE; P15291; -.
DR   DNASU; 2683; -.
DR   Ensembl; ENST00000379731; ENSP00000369055; ENSG00000086062. [P15291-1]
DR   GeneID; 2683; -.
DR   KEGG; hsa:2683; -.
DR   UCSC; uc003zsg.3; human. [P15291-1]
DR   CTD; 2683; -.
DR   DisGeNET; 2683; -.
DR   GeneCards; B4GALT1; -.
DR   GeneReviews; B4GALT1; -.
DR   HGNC; HGNC:924; B4GALT1.
DR   HPA; HPA010806; -.
DR   HPA; HPA010807; -.
DR   MalaCards; B4GALT1; -.
DR   MIM; 137060; gene.
DR   MIM; 607091; phenotype.
DR   neXtProt; NX_P15291; -.
DR   OpenTargets; ENSG00000086062; -.
DR   Orphanet; 79332; B4GALT1-CDG.
DR   PharmGKB; PA25223; -.
DR   eggNOG; KOG3916; Eukaryota.
DR   eggNOG; ENOG410ZYYA; LUCA.
DR   GeneTree; ENSGT00760000119140; -.
DR   HOVERGEN; HBG058334; -.
DR   InParanoid; P15291; -.
DR   KO; K07966; -.
DR   OMA; AHTRETM; -.
DR   OrthoDB; EOG091G0P66; -.
DR   PhylomeDB; P15291; -.
DR   TreeFam; TF312834; -.
DR   BioCyc; MetaCyc:HS01519-MONOMER; -.
DR   BRENDA; 2.4.1.133; 2681.
DR   BRENDA; 2.4.1.38; 2681.
DR   Reactome; R-HSA-1300644; Interaction With The Zona Pellucida.
DR   Reactome; R-HSA-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-HSA-5653890; Lactose synthesis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-975577; N-Glycan antennae elongation.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; B4GALT1; human.
DR   EvolutionaryTrace; P15291; -.
DR   GeneWiki; B4GALT1; -.
DR   GenomeRNAi; 2683; -.
DR   PRO; PR:P15291; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000086062; -.
DR   CleanEx; HS_B4GALT1; -.
DR   ExpressionAtlas; P15291; baseline and differential.
DR   Genevisible; P15291; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IDA:UniProtKB.
DR   GO; GO:0030057; C:desmosome; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0000138; C:Golgi trans cisterna; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0048487; F:beta-tubulin binding; IPI:UniProtKB.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IEA:Ensembl.
DR   GO; GO:0008378; F:galactosyltransferase activity; NAS:UniProtKB.
DR   GO; GO:0004461; F:lactose synthase activity; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0003945; F:N-acetyllactosamine synthase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0035250; F:UDP-galactosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0002526; P:acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0060055; P:angiogenesis involved in wound healing; IEA:Ensembl.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; IEA:Ensembl.
DR   GO; GO:0045136; P:development of secondary sexual characteristics; IEA:Ensembl.
DR   GO; GO:0002064; P:epithelial cell development; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006012; P:galactose metabolic process; IEA:Ensembl.
DR   GO; GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0005989; P:lactose biosynthetic process; TAS:Reactome.
DR   GO; GO:0050900; P:leukocyte migration; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0007341; P:penetration of zona pellucida; IEA:Ensembl.
DR   GO; GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IEA:Ensembl.
DR   GO; GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IEA:Ensembl.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:0060046; P:regulation of acrosome reaction; IEA:Ensembl.
DR   GO; GO:0051270; P:regulation of cellular component movement; IEA:Ensembl.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR003859; Galactosyl_T.
DR   InterPro; IPR027791; Galactosyl_T_C.
DR   InterPro; IPR027995; Galactosyl_T_N.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR19300; PTHR19300; 1.
DR   Pfam; PF02709; Glyco_transf_7C; 1.
DR   Pfam; PF13733; Glyco_transf_7N; 1.
DR   PRINTS; PR02050; B14GALTRFASE.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Cell membrane; Cell projection;
KW   Complete proteome; Congenital disorder of glycosylation;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Manganese; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Secreted;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    398       Beta-1,4-galactosyltransferase 1.
FT                                /FTId=PRO_0000012278.
FT   CHAIN         ?    398       Processed beta-1,4-galactosyltransferase
FT                                1.
FT                                /FTId=PRO_0000296229.
FT   TOPO_DOM      1     24       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     25     44       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     45    398       Lumenal. {ECO:0000255}.
FT   REGION      183    187       UDP-alpha-D-galactose binding.
FT   REGION      222    224       UDP-alpha-D-galactose binding.
FT                                {ECO:0000250}.
FT   REGION      249    250       UDP-alpha-D-galactose binding.
FT   REGION      312    315       N-acetyl-D-glucosamine binding.
FT   REGION      343    346       UDP-alpha-D-galactose binding.
FT   METAL       250    250       Manganese.
FT   METAL       343    343       Manganese; via tele nitrogen.
FT   BINDING     310    310       UDP-alpha-D-galactose.
FT                                {ECO:0000269|PubMed:16497331}.
FT   BINDING     355    355       N-acetyl-D-glucosamine.
FT                                {ECO:0000269|PubMed:16157350,
FT                                ECO:0000269|PubMed:19106107}.
FT   SITE         77     78       Cleavage; to produce soluble form.
FT   CARBOHYD    113    113       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    130    172
FT   DISULFID    243    262
FT   VAR_SEQ       1     13       Missing (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018802.
FT   VARIANT      21     21       R -> W (in dbSNP:rs1065764).
FT                                /FTId=VAR_054019.
FT   VARIANT     257    257       H -> R (in dbSNP:rs9169).
FT                                /FTId=VAR_054020.
FT   MUTAGEN     282    282       Y->G: Reduction in N-acetylglucosamine
FT                                binding. {ECO:0000269|PubMed:2120039}.
FT   MUTAGEN     285    285       Y->F: No change in enzymatic activity.
FT                                {ECO:0000269|PubMed:2120039}.
FT   MUTAGEN     307    307       Y->G: Reduction in N-acetylglucosamine
FT                                and UDP-galactose binding.
FT                                {ECO:0000269|PubMed:2120039}.
FT   MUTAGEN     308    308       W->G: Reduction in N-acetylglucosamine
FT                                binding. {ECO:0000269|PubMed:2120039}.
FT   MUTAGEN     310    310       W->G: Reduction in N-acetylglucosamine
FT                                binding. {ECO:0000269|PubMed:2120039}.
FT   MUTAGEN     340    340       M->H: Favors the closed conformation of
FT                                the enzyme.
FT                                {ECO:0000269|PubMed:16157350}.
FT   CONFLICT     10     10       G -> R (in Ref. 4; CAA31611 and 5;
FT                                BAA06188). {ECO:0000305}.
FT   CONFLICT     11     11       Missing (in Ref. 1; AAA35936, 3; AAB00776
FT                                and 6; AAA68220). {ECO:0000305}.
FT   CONFLICT     31     32       AL -> VW (in Ref. 1; AAA35936/AAA35937
FT                                and 6; AAA68220). {ECO:0000305}.
FT   CONFLICT     35     35       G -> R (in Ref. 4; CAA31611).
FT                                {ECO:0000305}.
FT   CONFLICT     76     76       E -> D (in Ref. 5; BAA06188).
FT                                {ECO:0000305}.
FT   CONFLICT     91    115       SSQPRPGGDSSPVVDSGPGPASNLT -> GKHAKSSFKQFL
FT                                LQIKELSNPIDLD (in Ref. 6; AAA68219).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       Y -> YGIY (in Ref. 1; CAA32247 and 3;
FT                                AAB00776). {ECO:0000305}.
FT   CONFLICT    260    260       Y -> D (in Ref. 6; AAA68218).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       L -> S (in Ref. 5; BAA06188).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       R -> T (in Ref. 5; BAA06188).
FT                                {ECO:0000305}.
FT   CONFLICT    340    341       MI -> PA (in Ref. 6; AAA68220).
FT                                {ECO:0000305}.
FT   HELIX       151    157       {ECO:0000244|PDB:2FY7}.
FT   TURN        163    165       {ECO:0000244|PDB:2FY7}.
FT   STRAND      170    173       {ECO:0000244|PDB:2FY7}.
FT   STRAND      177    186       {ECO:0000244|PDB:2FY7}.
FT   HELIX       188    204       {ECO:0000244|PDB:2FY7}.
FT   STRAND      208    216       {ECO:0000244|PDB:2FY7}.
FT   STRAND      218    220       {ECO:0000244|PDB:2FY7}.
FT   HELIX       224    238       {ECO:0000244|PDB:2FY7}.
FT   STRAND      243    247       {ECO:0000244|PDB:2FY7}.
FT   STRAND      251    255       {ECO:0000244|PDB:2FY7}.
FT   HELIX       274    276       {ECO:0000244|PDB:2FY7}.
FT   STRAND      288    293       {ECO:0000244|PDB:2FY7}.
FT   HELIX       294    299       {ECO:0000244|PDB:2FY7}.
FT   STRAND      309    312       {ECO:0000244|PDB:2AGD}.
FT   HELIX       313    323       {ECO:0000244|PDB:2FY7}.
FT   TURN        333    335       {ECO:0000244|PDB:2FY7}.
FT   STRAND      337    340       {ECO:0000244|PDB:2FY7}.
FT   HELIX       347    349       {ECO:0000244|PDB:4L41}.
FT   HELIX       359    365       {ECO:0000244|PDB:2FY7}.
FT   TURN        366    368       {ECO:0000244|PDB:2FY7}.
FT   HELIX       371    373       {ECO:0000244|PDB:2FY7}.
FT   STRAND      377    384       {ECO:0000244|PDB:2FY7}.
FT   STRAND      387    393       {ECO:0000244|PDB:2FY7}.
SQ   SEQUENCE   398 AA;  43920 MW;  29B224C83C61E165 CRC64;
     MRLREPLLSG SAAMPGASLQ RACRLLVAVC ALHLGVTLVY YLAGRDLSRL PQLVGVSTPL
     QGGSNSAAAI GQSSGELRTG GARPPPPLGA SSQPRPGGDS SPVVDSGPGP ASNLTSVPVP
     HTTALSLPAC PEESPLLVGP MLIEFNMPVD LELVAKQNPN VKMGGRYAPR DCVSPHKVAI
     IIPFRNRQEH LKYWLYYLHP VLQRQQLDYG IYVINQAGDT IFNRAKLLNV GFQEALKDYD
     YTCFVFSDVD LIPMNDHNAY RCFSQPRHIS VAMDKFGFSL PYVQYFGGVS ALSKQQFLTI
     NGFPNNYWGW GGEDDDIFNR LVFRGMSISR PNAVVGRCRM IRHSRDKKNE PNPQRFDRIA
     HTKETMLSDG LNSLTYQVLD VQRYPLYTQI TVDIGTPS
//
